Table B: GAAP to Non-GAAP reconciling items (Three Months Ended Q4 2016) |
|
|
|
| ||||||||||||||||||||||||
|
|
Cost of
|
|
Research
|
|
SG&A |
|
Amortization of
|
|
Impairment
|
|
Interest
|
|
Income
| ||||||||||||||
GAAP [i] |
|
$ |
328,220 |
|
|
$ |
92,188 |
|
|
$ |
94,076 |
|
|
$ |
52,104 |
|
|
$ |
1,960 |
|
|
$ |
(33,155) |
|
|
$ |
(790) |
|
[1] Stock based compensation, including costs related to modification of equity awards |
|
6,589 |
|
|
16,687 |
|
|
12,292 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
| |||||||
[2] Changes in value of deferred compensation plan |
|
42 |
|
|
147 |
|
|
292 |
|
|
— |
|
|
— |
|
|
(641) |
|
|
— |
| |||||||
[3] Merger, integration and related costs |
|
2,614 |
|
|
476 |
|
|
5,136 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
| |||||||
[4] Inventory Step-up related to acquisition accounting |
|
1,381 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
| |||||||
[5] Losses from equity method investments |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
8,766 |
|
|
— |
| |||||||
[6] Imputed interest on convertible debt, equity component amortization on convertible debt and others |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
3,482 |
|
|
— |
| |||||||
[7] Amortization of debt issuance costs |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
976 |
|
|
— |
| |||||||
[8] Amortization of Intangible assets |
|
— |
|
|
— |
|
|
— |
|
|
52,104 |
|
|
— |
|
|
— |
|
|
— |
| |||||||
[9] Impairment related to assets held for sale |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
1,960 |
|
|
— |
|
|
— |
| |||||||
[10] Restructuring costs, including executive severance |
|
— |
|
|
— |
|
|
17,237 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
| |||||||
[11] Tax impact of Non-GAAP adjustments |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(908) |
|
|
(2,442) |
| |||||||
Non - GAAP [ii] |
|
$ |
317,594 |
|
|
$ |
74,878 |
|
|
$ |
59,119 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(21,480) |
|
|
$ |
(3,232) |
|
Impact of reconciling items [ii - i] |
|
$ |
(10,626) |
|
|
$ |
(17,310) |
|
|
$ |
(34,957) |
|
|
$ |
(52,104) |
|
|
$ |
(1,960) |
|
|
$ |
11,675 |
|
|
$ |
(2,442) |
|